Genetics account for 20–90% of variability in drug disposition and effects. The rate of drug metabolism varies between individuals. People can be poor, intermediate, extensive or rapid metabolizers of drugs based on their genotype for CYP 450 family of enzymes. CYP 450 family of enzymes metabolize drugs to active or inactive metabolites. People who are poor or rapid metabolizers are prone to drug toxicity or lower effectiveness of drugs.
Our pharmacogenetic testing service, PGx Testing, uses a patient’s genes to determine how they will respond to a particular medicine or a combination of medicines and identifies their unique sensitivities to possible drug effects. As a result, healthcare providers can minimize or completely avoid trial-and-error dosing and substantially reduce the risk of potential adverse drug events.
.jpg)
.png)
.png)
